Uremic Toxin Receptor AhR Facilitates Renal Senescence and Fibrosis via Suppressing Mitochondrial Biogenesis
Advanced Science · 2024
DOI: 10.1002/advs.202402066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Hongyan Xie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Fibrosis, Renal Insufficiency, Chronic, Organelle Biogenesis. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University.
Abstract (Originalsprache)
Retention of metabolic end‐products in the bodily fluids of patients with chronic kidney disease (CKD) may lead to uremia. The uremic toxin indoxyl sulfate (IS), a tryptophan metabolite, is an endogenous ligand of aryl hydrocarbon receptor (AhR). It is clarified that the upregulation and activation of AhR by IS in tubular epithelial cells (TECs) promote renal senescence and fibrosis. Renal TEC‐specific knockout of AhR attenuates renal senescence and fibrosis, as well as the suppression of PGC1α‐mediated mitochondrial biogenesis in ischemia reperfusion (IR)‐ or IS‐treated CKD mice kidneys. Overexpression of peroxisome proliferator‐activated receptor gamma coactivator 1‐α (PGC1α) attenuates IS‐induced cell senescence and extracellular matrix production in cultured TECs. Mechanistically, AhR is able to interact with PGC1α and promotes the ubiquitin degradation of PGC1α via its E3 ubiquitin ligase activity. In summary, the elevation and activation of AhR by the accumulated uremic toxins in the progression of CKD accelerate renal senescence and fibrosis by suppressing mitochondrial biogenesis via promoting ubiquitination and proteasomal degradation of PGC1α.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
- Department of Nephrology, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China.
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Dali University, Dali, Yunnan, 671013, China.
- Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China.
- Shanghai Kidney Development and Pediatric Kidney Disease Research Center, Shanghai, 201102, China.
ORCID-Profile: Limin Lu
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University
Zitieren
APA
Xie, H., Yang, N., Lu, L., Sun, X., Li, J., Wang, X., Guo, H., Zhou, L., Liu, J., Wu, H., Yu, C., Zhang, W., & Lu, L. (2024). Uremic Toxin Receptor AhR Facilitates Renal Senescence and Fibrosis via Suppressing Mitochondrial Biogenesis. Advanced Science. https://doi.org/10.1002/advs.202402066
Vancouver
Xie H, Yang N, Lu L, Sun X, Li J, Wang X, et al. Uremic Toxin Receptor AhR Facilitates Renal Senescence and Fibrosis via Suppressing Mitochondrial Biogenesis. Advanced Science. 2024. doi:10.1002/advs.202402066
BibTeX
@article{Xie2024,
author = {Xie, Hongyan and Yang, Ninghao and Lu, Li and Sun, Xi'ang and Li, Jingyao and Wang, Xin and Guo, Hengjiang and Zhou, Li and Liu, Jun and Wu, Huijuan and Yu, Chen and Zhang, Wei and Lu, Limin},
title = {Uremic Toxin Receptor AhR Facilitates Renal Senescence and Fibrosis via Suppressing Mitochondrial Biogenesis},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202402066}
}
EUVIMED